Detalles de la búsqueda
1.
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.
Br J Cancer
; 126(5): 718-725, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34802051
2.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Eur J Haematol
; 108(5): 437-445, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35122325
3.
Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.
Lancet Oncol
; 19(12): 1641-1653, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30442502
4.
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Br J Haematol
; 181(6): 782-790, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29741758
5.
Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.
Haematologica
; 103(12): 2088-2096, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30237262
6.
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial.
Lancet
; 387(10027): 1551-1560, 2016 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26778538
7.
Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma.
Cancer
; 122(13): 2050-6, 2016 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27191689
8.
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Biol Blood Marrow Transplant
; 21(8): 1437-44, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25865648
9.
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
Clin Lymphoma Myeloma Leuk
; 23(9): e286-e296.e4, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37393120
10.
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
Br J Haematol
; 158(2): 174-185, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22640008
11.
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium.
Clin Lymphoma Myeloma Leuk
; 22(1): e41-e56, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34456159
12.
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment.
EJHaem
; 3(4): 1270-1276, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36467792
13.
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 16(5): 639-46, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20005967
14.
Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium.
Clin Lymphoma Myeloma Leuk
; 20(7): e352-e367, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32249195
15.
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.
Blood Cancer J
; 10(11): 111, 2020 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33149130
16.
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Biol Blood Marrow Transplant
; 15(2): 205-13, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19167680
17.
Pegylated liposomal doxorubicin plus bortezomib in relapsed or refractory multiple myeloma: efficacy and safety in patients with renal function impairment.
Clin Lymphoma Myeloma
; 8(6): 352-5, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19064400
18.
Organochlorine Levels in Plasma and Risk of Multiple Myeloma.
J Occup Environ Med
; 60(10): 911-916, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30289833
19.
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Clin Lymphoma Myeloma Leuk
; 18(11): e481-e491, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30100330
20.
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
J Clin Oncol
; 23(31): 7994-8002, 2005 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16204014